nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—INSR—polycystic ovary syndrome	0.338	0.551	CbGaD
Sunitinib—FLT4—polycystic ovary syndrome	0.276	0.449	CbGaD
Sunitinib—Tooth abscess—Metformin—polycystic ovary syndrome	0.0019	0.0698	CcSEcCtD
Sunitinib—Metoclopramide—CYP17A1—polycystic ovary syndrome	0.00166	1	CrCbGaD
Sunitinib—Nail disorder—Metformin—polycystic ovary syndrome	0.00122	0.0449	CcSEcCtD
Sunitinib—Fungal infection—Metformin—polycystic ovary syndrome	0.00103	0.0377	CcSEcCtD
Sunitinib—Blood disorder—Metformin—polycystic ovary syndrome	0.000951	0.0349	CcSEcCtD
Sunitinib—Nasal congestion—Metformin—polycystic ovary syndrome	0.000633	0.0232	CcSEcCtD
Sunitinib—Renal impairment—Metformin—polycystic ovary syndrome	0.000606	0.0222	CcSEcCtD
Sunitinib—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00059	0.0217	CcSEcCtD
Sunitinib—Pain in extremity—Metformin—polycystic ovary syndrome	0.000576	0.0212	CcSEcCtD
Sunitinib—Dehydration—Metformin—polycystic ovary syndrome	0.000536	0.0197	CcSEcCtD
Sunitinib—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000532	0.0195	CcSEcCtD
Sunitinib—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.000526	0.0193	CcSEcCtD
Sunitinib—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000515	0.0189	CcSEcCtD
Sunitinib—Abdominal distension—Metformin—polycystic ovary syndrome	0.000501	0.0184	CcSEcCtD
Sunitinib—Pancreatitis—Metformin—polycystic ovary syndrome	0.000488	0.0179	CcSEcCtD
Sunitinib—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000477	0.0175	CcSEcCtD
Sunitinib—Neutropenia—Metformin—polycystic ovary syndrome	0.000466	0.0171	CcSEcCtD
Sunitinib—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000463	0.017	CcSEcCtD
Sunitinib—Infestation NOS—Metformin—polycystic ovary syndrome	0.000444	0.0163	CcSEcCtD
Sunitinib—Infestation—Metformin—polycystic ovary syndrome	0.000444	0.0163	CcSEcCtD
Sunitinib—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000435	0.016	CcSEcCtD
Sunitinib—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00042	0.0154	CcSEcCtD
Sunitinib—Bradycardia—Metformin—polycystic ovary syndrome	0.000406	0.0149	CcSEcCtD
Sunitinib—Hepatitis—Metformin—polycystic ovary syndrome	0.000399	0.0146	CcSEcCtD
Sunitinib—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000397	0.0146	CcSEcCtD
Sunitinib—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000393	0.0144	CcSEcCtD
Sunitinib—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000392	0.0144	CcSEcCtD
Sunitinib—Eye disorder—Metformin—polycystic ovary syndrome	0.000373	0.0137	CcSEcCtD
Sunitinib—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00037	0.0136	CcSEcCtD
Sunitinib—Flushing—Metformin—polycystic ovary syndrome	0.00037	0.0136	CcSEcCtD
Sunitinib—Angiopathy—Metformin—polycystic ovary syndrome	0.000362	0.0133	CcSEcCtD
Sunitinib—Immune system disorder—Metformin—polycystic ovary syndrome	0.00036	0.0132	CcSEcCtD
Sunitinib—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000359	0.0132	CcSEcCtD
Sunitinib—Chills—Metformin—polycystic ovary syndrome	0.000358	0.0131	CcSEcCtD
Sunitinib—Malnutrition—Metformin—polycystic ovary syndrome	0.000347	0.0127	CcSEcCtD
Sunitinib—Erythema—Metformin—polycystic ovary syndrome	0.000347	0.0127	CcSEcCtD
Sunitinib—Flatulence—Metformin—polycystic ovary syndrome	0.000342	0.0126	CcSEcCtD
Sunitinib—Dysgeusia—Metformin—polycystic ovary syndrome	0.00034	0.0125	CcSEcCtD
Sunitinib—Muscle spasms—Metformin—polycystic ovary syndrome	0.000334	0.0122	CcSEcCtD
Sunitinib—Hypertension—Metformin—polycystic ovary syndrome	0.0003	0.011	CcSEcCtD
Sunitinib—Myalgia—Metformin—polycystic ovary syndrome	0.000295	0.0108	CcSEcCtD
Sunitinib—Chest pain—Metformin—polycystic ovary syndrome	0.000295	0.0108	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000293	0.0108	CcSEcCtD
Sunitinib—Oedema—Metformin—polycystic ovary syndrome	0.000283	0.0104	CcSEcCtD
Sunitinib—Infection—Metformin—polycystic ovary syndrome	0.000281	0.0103	CcSEcCtD
Sunitinib—Shock—Metformin—polycystic ovary syndrome	0.000279	0.0102	CcSEcCtD
Sunitinib—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000278	0.0102	CcSEcCtD
Sunitinib—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000277	0.0102	CcSEcCtD
Sunitinib—Skin disorder—Metformin—polycystic ovary syndrome	0.000275	0.0101	CcSEcCtD
Sunitinib—Anorexia—Metformin—polycystic ovary syndrome	0.00027	0.00991	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000258	0.00947	CcSEcCtD
Sunitinib—Paraesthesia—Metformin—polycystic ovary syndrome	0.000254	0.00933	CcSEcCtD
Sunitinib—Dyspnoea—Metformin—polycystic ovary syndrome	0.000253	0.00927	CcSEcCtD
Sunitinib—Dyspepsia—Metformin—polycystic ovary syndrome	0.000249	0.00915	CcSEcCtD
Sunitinib—Decreased appetite—Metformin—polycystic ovary syndrome	0.000246	0.00904	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000245	0.00898	CcSEcCtD
Sunitinib—Fatigue—Metformin—polycystic ovary syndrome	0.000244	0.00896	CcSEcCtD
Sunitinib—Constipation—Metformin—polycystic ovary syndrome	0.000242	0.00889	CcSEcCtD
Sunitinib—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000232	0.0085	CcSEcCtD
Sunitinib—Abdominal pain—Metformin—polycystic ovary syndrome	0.000224	0.00822	CcSEcCtD
Sunitinib—Asthenia—Metformin—polycystic ovary syndrome	0.000203	0.00746	CcSEcCtD
Sunitinib—Pruritus—Metformin—polycystic ovary syndrome	0.0002	0.00736	CcSEcCtD
Sunitinib—Diarrhoea—Metformin—polycystic ovary syndrome	0.000194	0.00711	CcSEcCtD
Sunitinib—Dizziness—Metformin—polycystic ovary syndrome	0.000187	0.00687	CcSEcCtD
Sunitinib—Vomiting—Metformin—polycystic ovary syndrome	0.00018	0.00661	CcSEcCtD
Sunitinib—Rash—Metformin—polycystic ovary syndrome	0.000179	0.00655	CcSEcCtD
Sunitinib—Dermatitis—Metformin—polycystic ovary syndrome	0.000178	0.00655	CcSEcCtD
Sunitinib—Headache—Metformin—polycystic ovary syndrome	0.000177	0.00651	CcSEcCtD
Sunitinib—Nausea—Metformin—polycystic ovary syndrome	0.000168	0.00617	CcSEcCtD
Sunitinib—MAP2K1—female gonad—polycystic ovary syndrome	0.000164	0.00106	CbGeAlD
Sunitinib—PTK2B—adrenal gland—polycystic ovary syndrome	0.000164	0.00106	CbGeAlD
Sunitinib—AXL—uterus—polycystic ovary syndrome	0.000163	0.00106	CbGeAlD
Sunitinib—FLT4—adrenal gland—polycystic ovary syndrome	0.000163	0.00106	CbGeAlD
Sunitinib—MAP3K3—endometrium—polycystic ovary syndrome	0.000162	0.00105	CbGeAlD
Sunitinib—MAP4K5—endometrium—polycystic ovary syndrome	0.000162	0.00105	CbGeAlD
Sunitinib—RPS6KB1—pituitary gland—polycystic ovary syndrome	0.000162	0.00105	CbGeAlD
Sunitinib—CSNK1A1—female gonad—polycystic ovary syndrome	0.000162	0.00105	CbGeAlD
Sunitinib—RPS6KB1—adipose tissue—polycystic ovary syndrome	0.000161	0.00105	CbGeAlD
Sunitinib—FGR—pituitary gland—polycystic ovary syndrome	0.000161	0.00104	CbGeAlD
Sunitinib—RET—pituitary gland—polycystic ovary syndrome	0.000161	0.00104	CbGeAlD
Sunitinib—MERTK—endocrine gland—polycystic ovary syndrome	0.000161	0.00104	CbGeAlD
Sunitinib—CSNK1A1—vagina—polycystic ovary syndrome	0.000161	0.00104	CbGeAlD
Sunitinib—FGFR1—adrenal gland—polycystic ovary syndrome	0.000161	0.00104	CbGeAlD
Sunitinib—CSNK1E—adrenal gland—polycystic ovary syndrome	0.000161	0.00104	CbGeAlD
Sunitinib—CLK1—female gonad—polycystic ovary syndrome	0.000161	0.00104	CbGeAlD
Sunitinib—KIT—embryo—polycystic ovary syndrome	0.000161	0.00104	CbGeAlD
Sunitinib—AXL—pituitary gland—polycystic ovary syndrome	0.00016	0.00104	CbGeAlD
Sunitinib—FGR—adipose tissue—polycystic ovary syndrome	0.00016	0.00104	CbGeAlD
Sunitinib—CLK1—vagina—polycystic ovary syndrome	0.00016	0.00104	CbGeAlD
Sunitinib—AXL—adipose tissue—polycystic ovary syndrome	0.00016	0.00104	CbGeAlD
Sunitinib—IRAK4—adrenal gland—polycystic ovary syndrome	0.000158	0.00103	CbGeAlD
Sunitinib—MAP4K4—endocrine gland—polycystic ovary syndrome	0.000158	0.00102	CbGeAlD
Sunitinib—CAMK2G—female gonad—polycystic ovary syndrome	0.000158	0.00102	CbGeAlD
Sunitinib—BMP2K—female gonad—polycystic ovary syndrome	0.000158	0.00102	CbGeAlD
Sunitinib—SLK—uterus—polycystic ovary syndrome	0.000157	0.00102	CbGeAlD
Sunitinib—CAMK2G—vagina—polycystic ovary syndrome	0.000157	0.00102	CbGeAlD
Sunitinib—BMP2K—vagina—polycystic ovary syndrome	0.000157	0.00102	CbGeAlD
Sunitinib—FLT1—endometrium—polycystic ovary syndrome	0.000157	0.00102	CbGeAlD
Sunitinib—PDGFRB—embryo—polycystic ovary syndrome	0.000157	0.00102	CbGeAlD
Sunitinib—LRRK2—female gonad—polycystic ovary syndrome	0.000156	0.00101	CbGeAlD
Sunitinib—FGFR2—uterus—polycystic ovary syndrome	0.000156	0.00101	CbGeAlD
Sunitinib—MAP3K12—endocrine gland—polycystic ovary syndrome	0.000156	0.00101	CbGeAlD
Sunitinib—FLT3—endocrine gland—polycystic ovary syndrome	0.000156	0.00101	CbGeAlD
Sunitinib—LRRK2—vagina—polycystic ovary syndrome	0.000155	0.00101	CbGeAlD
Sunitinib—EPHB6—endometrium—polycystic ovary syndrome	0.000155	0.00101	CbGeAlD
Sunitinib—MAP2K2—adrenal gland—polycystic ovary syndrome	0.000155	0.001	CbGeAlD
Sunitinib—ULK3—adrenal gland—polycystic ovary syndrome	0.000155	0.001	CbGeAlD
Sunitinib—SLK—pituitary gland—polycystic ovary syndrome	0.000154	0.001	CbGeAlD
Sunitinib—PRKAA1—female gonad—polycystic ovary syndrome	0.000154	0.001	CbGeAlD
Sunitinib—SLK—adipose tissue—polycystic ovary syndrome	0.000154	0.000998	CbGeAlD
Sunitinib—MAP3K2—adrenal gland—polycystic ovary syndrome	0.000154	0.000997	CbGeAlD
Sunitinib—RPS6KA3—endocrine gland—polycystic ovary syndrome	0.000154	0.000995	CbGeAlD
Sunitinib—FYN—uterus—polycystic ovary syndrome	0.000153	0.000992	CbGeAlD
Sunitinib—MAP2K1—endocrine gland—polycystic ovary syndrome	0.000153	0.000989	CbGeAlD
Sunitinib—FGFR2—adipose tissue—polycystic ovary syndrome	0.000152	0.000989	CbGeAlD
Sunitinib—PTK2B—female gonad—polycystic ovary syndrome	0.000152	0.000988	CbGeAlD
Sunitinib—JAK2—pituitary gland—polycystic ovary syndrome	0.000152	0.000987	CbGeAlD
Sunitinib—MAP3K7—adrenal gland—polycystic ovary syndrome	0.000152	0.000987	CbGeAlD
Sunitinib—FLT4—female gonad—polycystic ovary syndrome	0.000152	0.000986	CbGeAlD
Sunitinib—JAK2—adipose tissue—polycystic ovary syndrome	0.000152	0.000983	CbGeAlD
Sunitinib—PTK2B—vagina—polycystic ovary syndrome	0.000152	0.000982	CbGeAlD
Sunitinib—TBK1—adrenal gland—polycystic ovary syndrome	0.000151	0.000976	CbGeAlD
Sunitinib—CSNK1A1—endocrine gland—polycystic ovary syndrome	0.000151	0.000976	CbGeAlD
Sunitinib—FYN—pituitary gland—polycystic ovary syndrome	0.00015	0.000974	CbGeAlD
Sunitinib—FGFR1—female gonad—polycystic ovary syndrome	0.00015	0.000972	CbGeAlD
Sunitinib—CSNK1E—female gonad—polycystic ovary syndrome	0.00015	0.000972	CbGeAlD
Sunitinib—YES1—endometrium—polycystic ovary syndrome	0.00015	0.000971	CbGeAlD
Sunitinib—FYN—adipose tissue—polycystic ovary syndrome	0.00015	0.00097	CbGeAlD
Sunitinib—CLK1—endocrine gland—polycystic ovary syndrome	0.00015	0.00097	CbGeAlD
Sunitinib—TYK2—adrenal gland—polycystic ovary syndrome	0.00015	0.00097	CbGeAlD
Sunitinib—MAP4K5—uterus—polycystic ovary syndrome	0.000149	0.000969	CbGeAlD
Sunitinib—CSNK1E—vagina—polycystic ovary syndrome	0.000149	0.000967	CbGeAlD
Sunitinib—FGFR1—vagina—polycystic ovary syndrome	0.000149	0.000967	CbGeAlD
Sunitinib—KDR—adrenal cortex—polycystic ovary syndrome	0.000148	0.000963	CbGeAlD
Sunitinib—MAP2K5—adrenal cortex—polycystic ovary syndrome	0.000148	0.000963	CbGeAlD
Sunitinib—TAOK3—endometrium—polycystic ovary syndrome	0.000148	0.000959	CbGeAlD
Sunitinib—IRAK4—female gonad—polycystic ovary syndrome	0.000148	0.000957	CbGeAlD
Sunitinib—IRAK1—adrenal gland—polycystic ovary syndrome	0.000148	0.000957	CbGeAlD
Sunitinib—CAMK2G—endocrine gland—polycystic ovary syndrome	0.000147	0.000952	CbGeAlD
Sunitinib—BMP2K—endocrine gland—polycystic ovary syndrome	0.000147	0.000952	CbGeAlD
Sunitinib—MAP4K5—pituitary gland—polycystic ovary syndrome	0.000147	0.000952	CbGeAlD
Sunitinib—MAP3K3—pituitary gland—polycystic ovary syndrome	0.000147	0.000952	CbGeAlD
Sunitinib—IRAK4—vagina—polycystic ovary syndrome	0.000147	0.000951	CbGeAlD
Sunitinib—MAP4K5—adipose tissue—polycystic ovary syndrome	0.000146	0.000948	CbGeAlD
Sunitinib—MAP3K3—adipose tissue—polycystic ovary syndrome	0.000146	0.000948	CbGeAlD
Sunitinib—LRRK2—endocrine gland—polycystic ovary syndrome	0.000145	0.000943	CbGeAlD
Sunitinib—CSF1R—adrenal cortex—polycystic ovary syndrome	0.000145	0.000939	CbGeAlD
Sunitinib—RPS6KB1—adrenal gland—polycystic ovary syndrome	0.000145	0.000939	CbGeAlD
Sunitinib—FLT1—uterus—polycystic ovary syndrome	0.000145	0.000937	CbGeAlD
Sunitinib—MAP2K2—female gonad—polycystic ovary syndrome	0.000144	0.000936	CbGeAlD
Sunitinib—ULK3—female gonad—polycystic ovary syndrome	0.000144	0.000936	CbGeAlD
Sunitinib—FGR—adrenal gland—polycystic ovary syndrome	0.000144	0.000933	CbGeAlD
Sunitinib—RET—adrenal gland—polycystic ovary syndrome	0.000144	0.000933	CbGeAlD
Sunitinib—ULK3—vagina—polycystic ovary syndrome	0.000144	0.00093	CbGeAlD
Sunitinib—PRKAA1—endocrine gland—polycystic ovary syndrome	0.000143	0.00093	CbGeAlD
Sunitinib—AXL—adrenal gland—polycystic ovary syndrome	0.000143	0.00093	CbGeAlD
Sunitinib—MAP3K2—female gonad—polycystic ovary syndrome	0.000143	0.000929	CbGeAlD
Sunitinib—MAP3K7—female gonad—polycystic ovary syndrome	0.000142	0.000921	CbGeAlD
Sunitinib—FLT1—pituitary gland—polycystic ovary syndrome	0.000142	0.00092	CbGeAlD
Sunitinib—PTK2B—endocrine gland—polycystic ovary syndrome	0.000142	0.000919	CbGeAlD
Sunitinib—FLT4—endocrine gland—polycystic ovary syndrome	0.000141	0.000917	CbGeAlD
Sunitinib—FLT1—adipose tissue—polycystic ovary syndrome	0.000141	0.000916	CbGeAlD
Sunitinib—MAP3K7—vagina—polycystic ovary syndrome	0.000141	0.000915	CbGeAlD
Sunitinib—TBK1—female gonad—polycystic ovary syndrome	0.00014	0.00091	CbGeAlD
Sunitinib—EPHB6—pituitary gland—polycystic ovary syndrome	0.00014	0.000909	CbGeAlD
Sunitinib—EPHB6—adipose tissue—polycystic ovary syndrome	0.00014	0.000906	CbGeAlD
Sunitinib—TBK1—vagina—polycystic ovary syndrome	0.00014	0.000905	CbGeAlD
Sunitinib—CSNK1E—endocrine gland—polycystic ovary syndrome	0.000139	0.000904	CbGeAlD
Sunitinib—TYK2—female gonad—polycystic ovary syndrome	0.000139	0.000904	CbGeAlD
Sunitinib—TYK2—vagina—polycystic ovary syndrome	0.000139	0.000899	CbGeAlD
Sunitinib—YES1—uterus—polycystic ovary syndrome	0.000138	0.000895	CbGeAlD
Sunitinib—SLK—adrenal gland—polycystic ovary syndrome	0.000138	0.000895	CbGeAlD
Sunitinib—IRAK1—female gonad—polycystic ovary syndrome	0.000138	0.000892	CbGeAlD
Sunitinib—STK10—uterus—polycystic ovary syndrome	0.000137	0.000887	CbGeAlD
Sunitinib—FGFR2—adrenal gland—polycystic ovary syndrome	0.000137	0.000887	CbGeAlD
Sunitinib—TAOK3—uterus—polycystic ovary syndrome	0.000136	0.000884	CbGeAlD
Sunitinib—JAK2—adrenal gland—polycystic ovary syndrome	0.000136	0.000882	CbGeAlD
Sunitinib—YES1—pituitary gland—polycystic ovary syndrome	0.000136	0.000879	CbGeAlD
Sunitinib—PDGFRA—uterus—polycystic ovary syndrome	0.000135	0.000878	CbGeAlD
Sunitinib—RPS6KB1—female gonad—polycystic ovary syndrome	0.000135	0.000876	CbGeAlD
Sunitinib—YES1—adipose tissue—polycystic ovary syndrome	0.000135	0.000875	CbGeAlD
Sunitinib—MAP2K2—endocrine gland—polycystic ovary syndrome	0.000134	0.000871	CbGeAlD
Sunitinib—ULK3—endocrine gland—polycystic ovary syndrome	0.000134	0.000871	CbGeAlD
Sunitinib—RPS6KB1—vagina—polycystic ovary syndrome	0.000134	0.00087	CbGeAlD
Sunitinib—FGR—female gonad—polycystic ovary syndrome	0.000134	0.00087	CbGeAlD
Sunitinib—FYN—adrenal gland—polycystic ovary syndrome	0.000134	0.00087	CbGeAlD
Sunitinib—TAOK3—pituitary gland—polycystic ovary syndrome	0.000134	0.000868	CbGeAlD
Sunitinib—STK10—adipose tissue—polycystic ovary syndrome	0.000134	0.000867	CbGeAlD
Sunitinib—AXL—female gonad—polycystic ovary syndrome	0.000134	0.000867	CbGeAlD
Sunitinib—FGR—vagina—polycystic ovary syndrome	0.000133	0.000865	CbGeAlD
Sunitinib—MAP3K2—endocrine gland—polycystic ovary syndrome	0.000133	0.000864	CbGeAlD
Sunitinib—TAOK3—adipose tissue—polycystic ovary syndrome	0.000133	0.000864	CbGeAlD
Sunitinib—AXL—vagina—polycystic ovary syndrome	0.000133	0.000861	CbGeAlD
Sunitinib—MAP2K5—endometrium—polycystic ovary syndrome	0.000133	0.00086	CbGeAlD
Sunitinib—KDR—endometrium—polycystic ovary syndrome	0.000133	0.00086	CbGeAlD
Sunitinib—PDGFRA—adipose tissue—polycystic ovary syndrome	0.000132	0.000859	CbGeAlD
Sunitinib—MAP3K3—adrenal gland—polycystic ovary syndrome	0.000131	0.00085	CbGeAlD
Sunitinib—MAP4K5—adrenal gland—polycystic ovary syndrome	0.000131	0.00085	CbGeAlD
Sunitinib—TBK1—endocrine gland—polycystic ovary syndrome	0.000131	0.000846	CbGeAlD
Sunitinib—TYK2—endocrine gland—polycystic ovary syndrome	0.00013	0.000841	CbGeAlD
Sunitinib—CSF1R—endometrium—polycystic ovary syndrome	0.000129	0.000839	CbGeAlD
Sunitinib—SLK—female gonad—polycystic ovary syndrome	0.000129	0.000834	CbGeAlD
Sunitinib—PDGFRB—adrenal cortex—polycystic ovary syndrome	0.000129	0.000833	CbGeAlD
Sunitinib—SLK—vagina—polycystic ovary syndrome	0.000128	0.000829	CbGeAlD
Sunitinib—FGFR2—female gonad—polycystic ovary syndrome	0.000128	0.000827	CbGeAlD
Sunitinib—JAK2—female gonad—polycystic ovary syndrome	0.000127	0.000822	CbGeAlD
Sunitinib—FLT1—adrenal gland—polycystic ovary syndrome	0.000127	0.000822	CbGeAlD
Sunitinib—JAK2—vagina—polycystic ovary syndrome	0.000126	0.000817	CbGeAlD
Sunitinib—RPS6KB1—endocrine gland—polycystic ovary syndrome	0.000126	0.000814	CbGeAlD
Sunitinib—EPHB6—adrenal gland—polycystic ovary syndrome	0.000125	0.000812	CbGeAlD
Sunitinib—FYN—female gonad—polycystic ovary syndrome	0.000125	0.000811	CbGeAlD
Sunitinib—FGR—endocrine gland—polycystic ovary syndrome	0.000125	0.000809	CbGeAlD
Sunitinib—RET—endocrine gland—polycystic ovary syndrome	0.000125	0.000809	CbGeAlD
Sunitinib—FYN—vagina—polycystic ovary syndrome	0.000124	0.000806	CbGeAlD
Sunitinib—AXL—endocrine gland—polycystic ovary syndrome	0.000124	0.000806	CbGeAlD
Sunitinib—MAP3K3—female gonad—polycystic ovary syndrome	0.000122	0.000793	CbGeAlD
Sunitinib—MAP4K5—female gonad—polycystic ovary syndrome	0.000122	0.000793	CbGeAlD
Sunitinib—KDR—uterus—polycystic ovary syndrome	0.000122	0.000792	CbGeAlD
Sunitinib—MAP3K3—vagina—polycystic ovary syndrome	0.000122	0.000788	CbGeAlD
Sunitinib—MAP4K5—vagina—polycystic ovary syndrome	0.000122	0.000788	CbGeAlD
Sunitinib—YES1—adrenal gland—polycystic ovary syndrome	0.000121	0.000785	CbGeAlD
Sunitinib—STK10—adrenal gland—polycystic ovary syndrome	0.00012	0.000778	CbGeAlD
Sunitinib—KDR—pituitary gland—polycystic ovary syndrome	0.00012	0.000778	CbGeAlD
Sunitinib—MAP2K5—pituitary gland—polycystic ovary syndrome	0.00012	0.000778	CbGeAlD
Sunitinib—TAOK3—adrenal gland—polycystic ovary syndrome	0.00012	0.000775	CbGeAlD
Sunitinib—KDR—adipose tissue—polycystic ovary syndrome	0.000119	0.000775	CbGeAlD
Sunitinib—MAP2K5—adipose tissue—polycystic ovary syndrome	0.000119	0.000775	CbGeAlD
Sunitinib—CYP3A7—endocrine gland—polycystic ovary syndrome	0.000119	0.000773	CbGeAlD
Sunitinib—CSF1R—uterus—polycystic ovary syndrome	0.000119	0.000773	CbGeAlD
Sunitinib—PDGFRA—adrenal gland—polycystic ovary syndrome	0.000119	0.00077	CbGeAlD
Sunitinib—FGFR2—endocrine gland—polycystic ovary syndrome	0.000119	0.000769	CbGeAlD
Sunitinib—FLT1—female gonad—polycystic ovary syndrome	0.000118	0.000766	CbGeAlD
Sunitinib—JAK2—endocrine gland—polycystic ovary syndrome	0.000118	0.000765	CbGeAlD
Sunitinib—FLT1—vagina—polycystic ovary syndrome	0.000117	0.000762	CbGeAlD
Sunitinib—KIT—endometrium—polycystic ovary syndrome	0.000117	0.000762	CbGeAlD
Sunitinib—CSF1R—pituitary gland—polycystic ovary syndrome	0.000117	0.000759	CbGeAlD
Sunitinib—EPHB6—female gonad—polycystic ovary syndrome	0.000117	0.000758	CbGeAlD
Sunitinib—CSF1R—adipose tissue—polycystic ovary syndrome	0.000117	0.000756	CbGeAlD
Sunitinib—FYN—endocrine gland—polycystic ovary syndrome	0.000116	0.000754	CbGeAlD
Sunitinib—EPHB6—vagina—polycystic ovary syndrome	0.000116	0.000753	CbGeAlD
Sunitinib—PDGFRB—endometrium—polycystic ovary syndrome	0.000115	0.000744	CbGeAlD
Sunitinib—MAP4K5—endocrine gland—polycystic ovary syndrome	0.000114	0.000737	CbGeAlD
Sunitinib—MAP3K3—endocrine gland—polycystic ovary syndrome	0.000114	0.000737	CbGeAlD
Sunitinib—YES1—female gonad—polycystic ovary syndrome	0.000113	0.000732	CbGeAlD
Sunitinib—YES1—vagina—polycystic ovary syndrome	0.000112	0.000728	CbGeAlD
Sunitinib—STK10—female gonad—polycystic ovary syndrome	0.000112	0.000725	CbGeAlD
Sunitinib—TAOK3—female gonad—polycystic ovary syndrome	0.000111	0.000723	CbGeAlD
Sunitinib—STK10—vagina—polycystic ovary syndrome	0.000111	0.000721	CbGeAlD
Sunitinib—TAOK3—vagina—polycystic ovary syndrome	0.000111	0.000718	CbGeAlD
Sunitinib—PDGFRA—female gonad—polycystic ovary syndrome	0.000111	0.000718	CbGeAlD
Sunitinib—PDGFRA—vagina—polycystic ovary syndrome	0.00011	0.000714	CbGeAlD
Sunitinib—FLT1—endocrine gland—polycystic ovary syndrome	0.00011	0.000713	CbGeAlD
Sunitinib—KIT—uterus—polycystic ovary syndrome	0.000108	0.000702	CbGeAlD
Sunitinib—KDR—adrenal gland—polycystic ovary syndrome	0.000107	0.000695	CbGeAlD
Sunitinib—MAP2K5—adrenal gland—polycystic ovary syndrome	0.000107	0.000695	CbGeAlD
Sunitinib—KIT—pituitary gland—polycystic ovary syndrome	0.000106	0.000689	CbGeAlD
Sunitinib—KIT—adipose tissue—polycystic ovary syndrome	0.000106	0.000686	CbGeAlD
Sunitinib—PDGFRB—uterus—polycystic ovary syndrome	0.000106	0.000686	CbGeAlD
Sunitinib—YES1—endocrine gland—polycystic ovary syndrome	0.000105	0.000681	CbGeAlD
Sunitinib—CSF1R—adrenal gland—polycystic ovary syndrome	0.000105	0.000678	CbGeAlD
Sunitinib—STK10—endocrine gland—polycystic ovary syndrome	0.000104	0.000675	CbGeAlD
Sunitinib—PDGFRB—pituitary gland—polycystic ovary syndrome	0.000104	0.000673	CbGeAlD
Sunitinib—TAOK3—endocrine gland—polycystic ovary syndrome	0.000104	0.000672	CbGeAlD
Sunitinib—PDGFRB—adipose tissue—polycystic ovary syndrome	0.000103	0.00067	CbGeAlD
Sunitinib—PDGFRA—endocrine gland—polycystic ovary syndrome	0.000103	0.000668	CbGeAlD
Sunitinib—MAP2K5—female gonad—polycystic ovary syndrome	9.99e-05	0.000648	CbGeAlD
Sunitinib—KDR—female gonad—polycystic ovary syndrome	9.99e-05	0.000648	CbGeAlD
Sunitinib—KDR—vagina—polycystic ovary syndrome	9.93e-05	0.000644	CbGeAlD
Sunitinib—MAP2K5—vagina—polycystic ovary syndrome	9.93e-05	0.000644	CbGeAlD
Sunitinib—CSF1R—female gonad—polycystic ovary syndrome	9.75e-05	0.000632	CbGeAlD
Sunitinib—CSF1R—vagina—polycystic ovary syndrome	9.69e-05	0.000628	CbGeAlD
Sunitinib—KIT—adrenal gland—polycystic ovary syndrome	9.5e-05	0.000616	CbGeAlD
Sunitinib—KDR—endocrine gland—polycystic ovary syndrome	9.29e-05	0.000603	CbGeAlD
Sunitinib—MAP2K5—endocrine gland—polycystic ovary syndrome	9.29e-05	0.000603	CbGeAlD
Sunitinib—PDGFRB—adrenal gland—polycystic ovary syndrome	9.28e-05	0.000601	CbGeAlD
Sunitinib—CSF1R—endocrine gland—polycystic ovary syndrome	9.07e-05	0.000588	CbGeAlD
Sunitinib—KIT—female gonad—polycystic ovary syndrome	8.86e-05	0.000574	CbGeAlD
Sunitinib—KIT—vagina—polycystic ovary syndrome	8.8e-05	0.000571	CbGeAlD
Sunitinib—PDGFRB—female gonad—polycystic ovary syndrome	8.65e-05	0.000561	CbGeAlD
Sunitinib—PDGFRB—vagina—polycystic ovary syndrome	8.6e-05	0.000557	CbGeAlD
Sunitinib—ABCC4—uterus—polycystic ovary syndrome	8.42e-05	0.000546	CbGeAlD
Sunitinib—KIT—endocrine gland—polycystic ovary syndrome	8.24e-05	0.000534	CbGeAlD
Sunitinib—ABCC4—adipose tissue—polycystic ovary syndrome	8.23e-05	0.000534	CbGeAlD
Sunitinib—PDGFRB—endocrine gland—polycystic ovary syndrome	8.04e-05	0.000522	CbGeAlD
Sunitinib—ABCC4—adrenal gland—polycystic ovary syndrome	7.39e-05	0.000479	CbGeAlD
Sunitinib—KCNH2—endometrium—polycystic ovary syndrome	7.25e-05	0.00047	CbGeAlD
Sunitinib—ABCG2—adrenal cortex—polycystic ovary syndrome	7.22e-05	0.000468	CbGeAlD
Sunitinib—ABCC2—adrenal gland—polycystic ovary syndrome	7.15e-05	0.000464	CbGeAlD
Sunitinib—ABCC4—female gonad—polycystic ovary syndrome	6.89e-05	0.000446	CbGeAlD
Sunitinib—KCNH2—uterus—polycystic ovary syndrome	6.68e-05	0.000433	CbGeAlD
Sunitinib—KCNH2—pituitary gland—polycystic ovary syndrome	6.56e-05	0.000425	CbGeAlD
Sunitinib—ABCG2—endometrium—polycystic ovary syndrome	6.45e-05	0.000418	CbGeAlD
Sunitinib—ABCC4—endocrine gland—polycystic ovary syndrome	6.4e-05	0.000415	CbGeAlD
Sunitinib—ABCC2—endocrine gland—polycystic ovary syndrome	6.2e-05	0.000402	CbGeAlD
Sunitinib—ABCG2—uterus—polycystic ovary syndrome	5.94e-05	0.000385	CbGeAlD
Sunitinib—KCNH2—adrenal gland—polycystic ovary syndrome	5.86e-05	0.00038	CbGeAlD
Sunitinib—ABCG2—pituitary gland—polycystic ovary syndrome	5.84e-05	0.000378	CbGeAlD
Sunitinib—ABCG2—adipose tissue—polycystic ovary syndrome	5.81e-05	0.000377	CbGeAlD
Sunitinib—KCNH2—female gonad—polycystic ovary syndrome	5.46e-05	0.000354	CbGeAlD
Sunitinib—KCNH2—vagina—polycystic ovary syndrome	5.43e-05	0.000352	CbGeAlD
Sunitinib—CYP3A5—adipose tissue—polycystic ovary syndrome	5.4e-05	0.00035	CbGeAlD
Sunitinib—ABCG2—adrenal gland—polycystic ovary syndrome	5.21e-05	0.000338	CbGeAlD
Sunitinib—KCNH2—endocrine gland—polycystic ovary syndrome	5.08e-05	0.00033	CbGeAlD
Sunitinib—ABCG2—female gonad—polycystic ovary syndrome	4.86e-05	0.000315	CbGeAlD
Sunitinib—ABCG2—vagina—polycystic ovary syndrome	4.83e-05	0.000313	CbGeAlD
Sunitinib—CYP3A5—female gonad—polycystic ovary syndrome	4.51e-05	0.000293	CbGeAlD
Sunitinib—CYP3A5—vagina—polycystic ovary syndrome	4.49e-05	0.000291	CbGeAlD
Sunitinib—ABCB1—embryo—polycystic ovary syndrome	4.35e-05	0.000282	CbGeAlD
Sunitinib—CYP3A5—endocrine gland—polycystic ovary syndrome	4.2e-05	0.000272	CbGeAlD
Sunitinib—ABCB1—adrenal cortex—polycystic ovary syndrome	3.56e-05	0.000231	CbGeAlD
Sunitinib—ABCB1—endometrium—polycystic ovary syndrome	3.18e-05	0.000206	CbGeAlD
Sunitinib—CYP3A4—endocrine gland—polycystic ovary syndrome	3.15e-05	0.000204	CbGeAlD
Sunitinib—ABCB1—uterus—polycystic ovary syndrome	2.93e-05	0.00019	CbGeAlD
Sunitinib—ABCB1—pituitary gland—polycystic ovary syndrome	2.88e-05	0.000187	CbGeAlD
Sunitinib—ABCB1—adipose tissue—polycystic ovary syndrome	2.87e-05	0.000186	CbGeAlD
Sunitinib—ABCB1—adrenal gland—polycystic ovary syndrome	2.57e-05	0.000167	CbGeAlD
Sunitinib—ABCB1—female gonad—polycystic ovary syndrome	2.4e-05	0.000155	CbGeAlD
Sunitinib—ABCB1—vagina—polycystic ovary syndrome	2.38e-05	0.000154	CbGeAlD
Sunitinib—ABCB1—endocrine gland—polycystic ovary syndrome	2.23e-05	0.000145	CbGeAlD
Sunitinib—IRAK1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.14e-06	5.64e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—LEP—polycystic ovary syndrome	1.14e-06	5.64e-06	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—IL6—polycystic ovary syndrome	1.13e-06	5.6e-06	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—IL6—polycystic ovary syndrome	1.13e-06	5.6e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.13e-06	5.6e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—IL6—polycystic ovary syndrome	1.13e-06	5.59e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—NRG1—polycystic ovary syndrome	1.12e-06	5.55e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.12e-06	5.51e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.11e-06	5.51e-06	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—IL6—polycystic ovary syndrome	1.11e-06	5.5e-06	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—IL6—polycystic ovary syndrome	1.11e-06	5.5e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—AKT2—polycystic ovary syndrome	1.11e-06	5.49e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—SERPINE1—polycystic ovary syndrome	1.11e-06	5.49e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.11e-06	5.48e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—IL6—polycystic ovary syndrome	1.11e-06	5.47e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—BCL2—polycystic ovary syndrome	1.11e-06	5.46e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—SERPINE1—polycystic ovary syndrome	1.1e-06	5.46e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	1.1e-06	5.44e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—POMC—polycystic ovary syndrome	1.1e-06	5.43e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—BCL2—polycystic ovary syndrome	1.1e-06	5.43e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.1e-06	5.42e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.09e-06	5.41e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—INS—polycystic ovary syndrome	1.09e-06	5.4e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	1.09e-06	5.39e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.09e-06	5.38e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.08e-06	5.35e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—IL6—polycystic ovary syndrome	1.08e-06	5.35e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.08e-06	5.32e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—IL6—polycystic ovary syndrome	1.08e-06	5.32e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IRS1—polycystic ovary syndrome	1.08e-06	5.31e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IRS1—polycystic ovary syndrome	1.08e-06	5.31e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—TH—polycystic ovary syndrome	1.07e-06	5.29e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—POMC—polycystic ovary syndrome	1.07e-06	5.28e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—INS—polycystic ovary syndrome	1.06e-06	5.25e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.06e-06	5.23e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.06e-06	5.23e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.06e-06	5.23e-06	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—IL6—polycystic ovary syndrome	1.06e-06	5.22e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.06e-06	5.22e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—SERPINE1—polycystic ovary syndrome	1.06e-06	5.21e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—POMC—polycystic ovary syndrome	1.05e-06	5.21e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—LEP—polycystic ovary syndrome	1.05e-06	5.2e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—BCL2—polycystic ovary syndrome	1.05e-06	5.19e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IRS2—polycystic ovary syndrome	1.05e-06	5.19e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—INS—polycystic ovary syndrome	1.05e-06	5.18e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.05e-06	5.17e-06	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—IL6—polycystic ovary syndrome	1.05e-06	5.17e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—IL6—polycystic ovary syndrome	1.04e-06	5.16e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	1.04e-06	5.14e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—POMC—polycystic ovary syndrome	1.04e-06	5.12e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—POMC—polycystic ovary syndrome	1.04e-06	5.12e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.03e-06	5.11e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—INS—polycystic ovary syndrome	1.03e-06	5.09e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—INS—polycystic ovary syndrome	1.03e-06	5.09e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—LEP—polycystic ovary syndrome	1.03e-06	5.08e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.03e-06	5.07e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	1.03e-06	5.07e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.03e-06	5.07e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.02e-06	5.05e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.02e-06	5.04e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—IL6—polycystic ovary syndrome	1.02e-06	5.03e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IRS1—polycystic ovary syndrome	1.02e-06	5.03e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	1.02e-06	5.03e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.02e-06	5.02e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.01e-06	5.01e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.01e-06	5.01e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.01e-06	5e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IRS2—polycystic ovary syndrome	1.01e-06	5e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IRS2—polycystic ovary syndrome	1.01e-06	4.98e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1e-06	4.96e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1e-06	4.96e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IGF1—polycystic ovary syndrome	9.96e-07	4.92e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IGF1—polycystic ovary syndrome	9.96e-07	4.92e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AKT2—polycystic ovary syndrome	9.95e-07	4.92e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AKT2—polycystic ovary syndrome	9.95e-07	4.92e-06	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—IL6—polycystic ovary syndrome	9.92e-07	4.9e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—LEP—polycystic ovary syndrome	9.91e-07	4.9e-06	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—IL6—polycystic ovary syndrome	9.89e-07	4.89e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—LEP—polycystic ovary syndrome	9.85e-07	4.87e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—POMC—polycystic ovary syndrome	9.83e-07	4.86e-06	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—IL6—polycystic ovary syndrome	9.82e-07	4.85e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—POMC—polycystic ovary syndrome	9.8e-07	4.84e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	9.79e-07	4.84e-06	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—IL6—polycystic ovary syndrome	9.78e-07	4.83e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—INS—polycystic ovary syndrome	9.77e-07	4.83e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—IL6—polycystic ovary syndrome	9.77e-07	4.83e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.75e-07	4.82e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—INS—polycystic ovary syndrome	9.75e-07	4.82e-06	CbGpPWpGaD
Sunitinib—BLK—Immune System—IL6—polycystic ovary syndrome	9.68e-07	4.79e-06	CbGpPWpGaD
Sunitinib—FGR—Immune System—IL6—polycystic ovary syndrome	9.65e-07	4.77e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.63e-07	4.76e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IRS2—polycystic ovary syndrome	9.62e-07	4.76e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	9.48e-07	4.68e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.46e-07	4.67e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.46e-07	4.67e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IGF1—polycystic ovary syndrome	9.45e-07	4.67e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AKT2—polycystic ovary syndrome	9.44e-07	4.67e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IGF1—polycystic ovary syndrome	9.43e-07	4.66e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AKT2—polycystic ovary syndrome	9.42e-07	4.66e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—LEP—polycystic ovary syndrome	9.42e-07	4.65e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IRS1—polycystic ovary syndrome	9.4e-07	4.64e-06	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—IL6—polycystic ovary syndrome	9.33e-07	4.61e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	9.33e-07	4.61e-06	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—IL6—polycystic ovary syndrome	9.32e-07	4.61e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.28e-07	4.58e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	9.21e-07	4.55e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IRS1—polycystic ovary syndrome	9.17e-07	4.53e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—POMC—polycystic ovary syndrome	9.05e-07	4.47e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—INS—polycystic ovary syndrome	9e-07	4.45e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.97e-07	4.44e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.95e-07	4.42e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.93e-07	4.42e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.88e-07	4.39e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IRS1—polycystic ovary syndrome	8.84e-07	4.37e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—POMC—polycystic ovary syndrome	8.83e-07	4.36e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IRS1—polycystic ovary syndrome	8.79e-07	4.34e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—IL6—polycystic ovary syndrome	8.79e-07	4.34e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	8.79e-07	4.34e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—INS—polycystic ovary syndrome	8.78e-07	4.34e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	8.73e-07	4.32e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—IL6—polycystic ovary syndrome	8.72e-07	4.31e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IGF1—polycystic ovary syndrome	8.7e-07	4.3e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AKT2—polycystic ovary syndrome	8.7e-07	4.3e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.61e-07	4.25e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.61e-07	4.25e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—POMC—polycystic ovary syndrome	8.51e-07	4.21e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IGF1—polycystic ovary syndrome	8.49e-07	4.2e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AKT2—polycystic ovary syndrome	8.49e-07	4.19e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—POMC—polycystic ovary syndrome	8.46e-07	4.18e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—INS—polycystic ovary syndrome	8.46e-07	4.18e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—INS—polycystic ovary syndrome	8.42e-07	4.16e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IRS1—polycystic ovary syndrome	8.4e-07	4.15e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.39e-07	4.15e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	8.32e-07	4.11e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	8.32e-07	4.11e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.26e-07	4.08e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	8.25e-07	4.08e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—POMC—polycystic ovary syndrome	8.21e-07	4.06e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IGF1—polycystic ovary syndrome	8.19e-07	4.05e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AKT2—polycystic ovary syndrome	8.18e-07	4.04e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—INS—polycystic ovary syndrome	8.16e-07	4.03e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.14e-07	4.02e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	8.14e-07	4.02e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.14e-07	4.02e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—INS—polycystic ovary syndrome	8.09e-07	4e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—POMC—polycystic ovary syndrome	8.09e-07	4e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—TH—polycystic ovary syndrome	8.07e-07	3.99e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.06e-07	3.99e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—INS—polycystic ovary syndrome	8.04e-07	3.98e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.01e-07	3.96e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	7.89e-07	3.9e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	7.85e-07	3.88e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—IL6—polycystic ovary syndrome	7.85e-07	3.88e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	7.83e-07	3.87e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL6—polycystic ovary syndrome	7.79e-07	3.85e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IGF1—polycystic ovary syndrome	7.78e-07	3.85e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AKT2—polycystic ovary syndrome	7.78e-07	3.84e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.77e-07	3.84e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.73e-07	3.82e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	7.59e-07	3.75e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IL6—polycystic ovary syndrome	7.53e-07	3.72e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL6—polycystic ovary syndrome	7.39e-07	3.65e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.39e-07	3.65e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	7.38e-07	3.65e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	7.35e-07	3.63e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.28e-07	3.6e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL6—polycystic ovary syndrome	7.17e-07	3.55e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL6—polycystic ovary syndrome	7.08e-07	3.5e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL6—polycystic ovary syndrome	7.07e-07	3.49e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL6—polycystic ovary syndrome	7e-07	3.46e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	6.98e-07	3.45e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL6—polycystic ovary syndrome	6.96e-07	3.44e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL6—polycystic ovary syndrome	6.96e-07	3.44e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.91e-07	3.41e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.76e-07	3.34e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.71e-07	3.31e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL6—polycystic ovary syndrome	6.66e-07	3.29e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—IL6—polycystic ovary syndrome	6.62e-07	3.27e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.62e-07	3.27e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL6—polycystic ovary syndrome	6.6e-07	3.26e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	6.59e-07	3.26e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL6—polycystic ovary syndrome	6.59e-07	3.26e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—IL6—polycystic ovary syndrome	6.54e-07	3.23e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.52e-07	3.22e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.5e-07	3.21e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.5e-07	3.21e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—polycystic ovary syndrome	6.42e-07	3.17e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—polycystic ovary syndrome	6.42e-07	3.17e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	6.28e-07	3.1e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.26e-07	3.09e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—polycystic ovary syndrome	6.23e-07	3.08e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.18e-07	3.06e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—polycystic ovary syndrome	6.18e-07	3.05e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.17e-07	3.05e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.16e-07	3.04e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—polycystic ovary syndrome	6.14e-07	3.03e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—polycystic ovary syndrome	6.1e-07	3.01e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—polycystic ovary syndrome	6.08e-07	3.01e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—polycystic ovary syndrome	6.08e-07	3.01e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	5.96e-07	2.95e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—polycystic ovary syndrome	5.95e-07	2.94e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—polycystic ovary syndrome	5.95e-07	2.94e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	5.95e-07	2.94e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—polycystic ovary syndrome	5.95e-07	2.94e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—polycystic ovary syndrome	5.93e-07	2.93e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	5.88e-07	2.91e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—INS—polycystic ovary syndrome	5.85e-07	2.89e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.84e-07	2.89e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—polycystic ovary syndrome	5.8e-07	2.87e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.75e-07	2.84e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—polycystic ovary syndrome	5.72e-07	2.83e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—polycystic ovary syndrome	5.69e-07	2.81e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.68e-07	2.81e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—polycystic ovary syndrome	5.61e-07	2.77e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	5.55e-07	2.74e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.55e-07	2.74e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—polycystic ovary syndrome	5.48e-07	2.71e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—polycystic ovary syndrome	5.44e-07	2.69e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.35e-07	2.64e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.32e-07	2.63e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—polycystic ovary syndrome	5.28e-07	2.61e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—polycystic ovary syndrome	5.25e-07	2.6e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.08e-07	2.51e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—polycystic ovary syndrome	5.04e-07	2.49e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—polycystic ovary syndrome	5.02e-07	2.48e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.97e-07	2.46e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.84e-07	2.39e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—polycystic ovary syndrome	4.78e-07	2.36e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—polycystic ovary syndrome	4.64e-07	2.29e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—polycystic ovary syndrome	4.58e-07	2.26e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.55e-07	2.25e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.5e-07	2.22e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—polycystic ovary syndrome	4.5e-07	2.22e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—polycystic ovary syndrome	4.5e-07	2.22e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.44e-07	2.19e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.41e-07	2.18e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—polycystic ovary syndrome	4.27e-07	2.11e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—polycystic ovary syndrome	4.26e-07	2.1e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.06e-07	2.01e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—polycystic ovary syndrome	3.93e-07	1.94e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.87e-07	1.91e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—polycystic ovary syndrome	3.84e-07	1.9e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—polycystic ovary syndrome	3.7e-07	1.83e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—polycystic ovary syndrome	3.68e-07	1.82e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.67e-07	1.81e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—polycystic ovary syndrome	3.52e-07	1.74e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.42e-07	1.69e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.77e-07	1.37e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.73e-07	1.35e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.72e-07	1.34e-06	CbGpPWpGaD
